Introduction
============

Familial adenomatous polyposis (FAP) is a rare form of colorectal cancer caused by germline mutations in the adenomatous polyposis coli (APC) gene. Approximately 70--90% of FAP patients have identifiable germline mutations in *APC*\[[@B1],[@B2]\]. FAP is clinically characterized by the formation of hundreds to thousands of adenomas that carpet the entire colon and rectum \[[@B3]\]. Although initially benign the risk of malignant transformation increases with age such that, if left untreated, colorectal carcinoma usually develops before the age of 40 years \[[@B4]\].

Loss of APC results in dysregulation of the Wnt signalling pathway that leads to the constitutional activation of the transcription factor Tcf-4, which has been associated with adenoma formation \[[@B5]\]. Alterations in Wnt signalling cause stem cells to retain their ability to divide in the upper intestinal crypt, thereby forming monocryptal adenomas \[[@B6]\]. Eventually the adenomas may acquire metastatic potential, resulting in carcinoma development \[[@B7]\]. Not all adenomas will progress to malignant tumours; however, due to the abundance of adenomas carcinoma development is virtually assured \[[@B8]\].

Apart from the apparent loss of APC function, little is known about the molecular processes involved in adenoma initiation \[[@B6]\]. Similarly, the molecular events occurring during the transformation of adenomas into carcinomas are poorly understood, as are the mechanisms that underlie the development of extra-colonic disease in FAP.

It is well established that FAP patients are susceptible to benign extra-colonic tumours, including desmoid tumours \[[@B3]\]. Although rare in the general population, desmoids occur in approximately 10% of FAP patients and they are the second most common cause of death \[[@B9]\]. Desmoid tumours are poorly encapsulated and consist of spindle-shaped fibroblast cells with varying quantities of collagen \[[@B10]\]. Despite their apparent inability to metastasize, desmoid tumours can be extremely aggressive \[[@B11]\].

It has been speculated that desmoid formation is a result of an abnormal wound healing response \[[@B12]\]. Desmoids can affect surrounding viscera, causing potentially fatal complications \[[@B13]\]. FAP-associated desmoid tumours are usually associated with germline *APC*mutations \[[@B14]\], but somatic *APC*mutations have been detected in sporadic desmoid tumours \[[@B15]\].

Microarray technology has an enormous potential for applications in the endeavour to better understand tumours and their development \[[@B16]\]. The ability to detect expression levels of thousands of genes can identify particular genes that are either up- or down-regulated in different tumour types \[[@B17]\]. Tumours that are currently categorized by similar morphology, such as desmoid tumours, may be more usefully divided into subtypes according to their expression profiles \[[@B18]\]. Particular expression profiles in tumours may also be capable of predicting the clinical outcome in specific patients in the early stages of tumour development \[[@B18]\]. In colorectal cancer, gene expression profiles of adenomas and adenocarcinomas have been compared and subsets of genes expressed at common levels in both lesions have been identified as well as expression patterns that are unique to each \[[@B19]\]. Gene expression profiling has the potential to identify factors involved in the malignant transformation of adenomas, and may aid in the diagnosis of benign versus malignant disease.

Although genome-wide expression studies have been reported on FAP adenomas and desmoid tumours, the present one of the first to compare the two tissue types. The first aim of this study was to identify distinct gene expression profiles for colorectal and stomach FAP adenomas and desmoid tumours. The second aim was to determine the similarity between the gene expression profiles in FAP adenomas and desmoid tumours to identify mechanisms important in regulating formation of these lesions. To achieve this, mRNA from normal colon, FAP stomach and colon adenomas and desmoid tumours was measured using whole human genome expression BeadChips (Illumina). The findings of this study further our understanding of the mechanisms underlying FAP and desmoid tumour formation.

Materials and methods
=====================

FAP adenoma and tumour tissue and controls
------------------------------------------

Frozen adenoma tissue from 4 FAP patients was available for this study. Colorectal FAP adenoma A was from an individual aged 40 at the time of surgery. Genetic testing revealed a heterozygous A5465T change in the APC gene, causing a missense change from aspartic acid to valine at position 1822 in the amino acid sequence. The specimen obtained for this study was obtained as a result of a proctocolectomy. The pathology report indicated that over 100 tubulovillous adenomas were present in the original specimen, with no evidence of invasive tumour. Patients B, C and D harboured the same frameshift mutation, a 4 base pair deletion at position 3462--3465 of the APC gene. Patient B was diagnosed with FAP at the age of 11 years, patient C at 13 years of age, and patient D at the age of 37 years. One gastric adenoma was obtained from patient D, in addition to a colonic adenoma. Normal colon tissue from 7 healthy individuals with no history of FAP or desmoid disease was used as a mixed reference sample for this study.

Desmoid Disease Tissue
----------------------

Desmoid tumour tissue from two individuals was available for this study. Patient A had FAP-associated desmoid disease. There was a family history of FAP, but no known history of desmoid disease. The individual harboured a 1 bp deletion in exon 15 of the APC gene resulting in a frameshift that introduced a premature stop codon at amino acid position 964. Patient B had a family history of FAP and desmoid disease. This patient harboured a 17 bp duplication in exon 15 of the APC gene, which introduced a premature stop codon at amino acid position 1969. A previously established fibroblast cell line from a healthy individual with no history of FAP or desmoid disease was used as a control for this study. The fibroblast cell line was cultured in 1× Complete DMEM media at 37°C (5% CO~2~).

RNA Extraction
--------------

2--3 mm^2^pieces of fresh frozen FAP adenoma and desmoid tumour tissue were cut from the original sample and transferred immediately to 1 ml Trizol reagent (Invitrogen, USA). Similarly, approximately 1--10 × 10^6^control fibroblast cells were lysed in 1 ml Trizol reagent (Invitrogen, USA). RNA was extracted per manufacturer\'s instructions. The RNA pellet was washed with 75% ethanol, before being dissolved in 20 μl water.

The total RNA was purified using a Qiagen RNeasy MiniElute Cleanup Kit as per manufacturer\'s instructions. The concentration of the purified total RNA samples was measured using a Quant-It RiboGreen RNA Assay Kit (Invitrogen, USA) and a fluorometer (Fluostar OPTIMA) as per manufacturer\'s instructions.

RNA amplification
-----------------

To synthesise first and second strand cDNA and amplify biotinylated cRNA from the total RNA, an Illumina Totalprep RNA Amplification Kit was used as per manufacturer\'s instructions.

The purified cRNA samples were quantified to determine the volume required for the BeadChip hybridisation step via the Quant-iT RiboGreen RNA Assay Kit as described previously.

Illumina BeadChip Procedure
---------------------------

Hybridisation to the Illumina Sentrix 8 BeadChip was performed according to the manufacturer\'s instructions without modification. The Sentrix 8 BeadChips were read using an Illumina Beadarray reader (San Diego, CA, USA).

Data Analysis
-------------

Analysis and normalisation of expression data from the 24,000 transcripts was carried out using BeadStudio 2.0 (Illumina, San Diego, CA, USA). The t-test error model and cubic spline normalisation was used for all samples. A differential analysis was applied to all adenoma and tumour samples using the Illumina custom test of significance, utilising the mixed normal colon control as the reference group. GeneSpring 5.0 (Agilant, Santa Clara, CA, USA) used standard correlation and distance to create dendrograms (Experiment trees) to show relationships between gene expression profiles. A second dendrogram (Gene tree) was created for each gene list using standard correlation and distance to show relationships between the expression levels of genes across the groups.

Results
=======

Gene expression data from over 23,000 genes on Illumina HumRef-8 BeadChips was analysed and normalised using Illumina BeadStudio 2.0 software. Cubic spline normalisation and the t-test error model were employed for all the FAP adenoma, normal colon and desmoid tumour samples. Correlation analyses identified the average R^2^value of the duplicates for each sample as 0.950 ± 0.04. An average of each duplicate pair was then taken before additional analysis was carried out.

Differential gene expression analysis in FAP adenomas and healthy colon tissue
------------------------------------------------------------------------------

Differential analysis using the mixed normal colon control as the reference group was applied to all adenoma and tumour samples. Genes in each analysis were excluded if their fluorescence detection score was less than 0.99, and if their differential score was less than 13 (p \> 0.05). From the genes that met the exclusion criteria, according to detection and differential scores, lists were generated for genes both up- and down-regulated more than 2-fold in the FAP adenoma samples compared to the mixed normal colon control. The genes commonly up- and down-regulated across all the FAP adenomas are shown in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"} and genes that were commonly up- or down-regulated across the 4 colorectal FAP adenomas only are shown in Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"} respectively.

###### 

Genes commonly up-regulated more than 2-fold in all FAP polyps compared to normal colon

  **Symbol**                                   **Gene Name**
  -------------------------------------------- ------------------------------------------------
  *Transcription/Transcriptional Regulation*   
  TBPL1                                        TBP-like 1
                                               
  *Other*                                      
  ZCWCC2                                       Zinc finger, CW-type with coiled-coil domain 2
  KIAA1324                                     Maba1
  FLJ20366                                     Hypothetical protein FLJ20366
  ATOH8                                        Atonal homolog 8 (*Drosophila*)

###### 

Genes commonly down-regulated more than 2-fold in all FAP polyps compared to normal colon

  **Symbol**              **Gene Name**
  ----------------------- -------------------------------------------------------------------------------------------
  *Cell Cycle Control*    
  PPP3CB                  Protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta)
                          
  *Transport*             
  SLC20A1                 Solute carrier family 20 (phosphate transporter), member 1
  P2RX4                   Purinergic receptor P2X, ligand-gated ion channel, 4, tv-2
                          
  *Metabolism*            
  PC                      Pyruvate carboxylase, nuclear gene encoding mitochondrial protein, tv-2
  PRSS3                   Protease, serine, 3 (mesotrypsin)
  ST6GALNAC6              CMP-NeuAC: (beta)-N-acetylgalactosaminide (alpha) 2,6-sialyltransferase member IV
                          
  *Signal Transduction*   
  IL2RG                   Interleukin 2 receptor, gamma (severe combined immunodeficiency)
  TJP3                    Tight junction protein 3 (zona occludens 3)
                          
  *Cell Adhesion*         
  CDC42                   Cell division cycle 42 (GTP binding protein, 25 kDa), tv-2
  GSN                     Gelsolin (amyloidosis, Finnish type), tv-2
  TAGLN                   Transgelin
                          
  *Apoptosis*             
  DAPK3                   Death-associated protein kinase 3
                          
  *Structural*            
  KRT19                   Keratin 19
  TPM2                    Tropomyosin 2 (beta)
                          
  *Other*                 
  CTGF                    Connective tissue growth factor
  EPS8L2                  EPS8-like 2
  LRRC1                   Leucine rich repeat containing 1
  NS5ATP13TP2             NS5ATP13TP2 protein
  PTPRR                   Protein tyrosine phosphatase, receptor type, R, tv-2
  RICH1                   RhoGAP interacting with CIP4 homologs 1
  SMTN                    Smoothelin, tv-2

###### 

Genes commonly up-regulated 2-fold or more in colorectal FAP polyps compared to normal colon

  **Symbol**                                   **Gene Name**
  -------------------------------------------- ------------------------------------------------------------------------------------------------------
  *Cell Cycle Control*                         
  CCNB2                                        Cyclin B2
  CDKN3                                        Cyclin-dependent kinase inhibitor 3
  AURKB                                        Aurora kinase B
                                               
  *Cell Cycle*                                 
  HCAP-G                                       Chromosome condensation protein G
  PRC1                                         Protein regulator of cytokinesis 1, tv-1
  KIF2C                                        Kinesin family member 2C
  CHC1                                         Chromosome condensation 1
  SMC4L1                                       SMC4 structural maintenance of chromosome 4-like 1 (yeast)
  Pfs2                                         DNA replication complex GINS protein PSF2
  RNASEH2A                                     Ribonuclease H2, large subunit
                                               
  *Transcription/Transcriptional Regulation*   
  FLJ20315                                     Hypothetical protein FLJ20315
  TBPL1                                        TBP-like 1
  LOC89958                                     Hypothetical protein LOC89958
  HMGN1                                        High-mobility group nucleosome binding domain 1
  ZNF22                                        Zinc finger protein 22 (KOX 15)
  PTTG1                                        Pituitary tumour-transforming 1
  NFE2L3                                       Nuclear factor (erythroid-derived 2)-like 3
  SOX9                                         SRY (sex determining region Y)-box 9 (campomelic dysplasia, autosomal sex-reversal)
                                               
  *Transport*                                  
  SLC12A2                                      Solute carrier family 12 (sodium/potassium/chloride transporters) member 2
  CLCA1                                        Chloride channel, calcium activated, family member 1
  LCN2                                         Lipocalin 2 (oncogene 24p3)
                                               
  *Metabolism*                                 
  SORD                                         Sorbitol dehydrogenase
  TPRT                                         Trans-prenyltransferase
  QTRT1                                        Queuine tRNA-ribosyltransferase 1 (tRNA-guanine transglycosylase)
  PAICS                                        Phosphoribosylaminoimidazole carboxylase, Phosphoribosylaminoimidazole succinocarboxamide synthetase
  DPH2L2                                       DPH2-like 2 (S. cerevisiae), tv-1
  ALOX5                                        Arachidonate 5-lipoxygenase
  IARS                                         Isoleucine-tRNA synthetase, tv-short
  BRIX                                         BRIX
  TK1                                          Thymidine kinase 1, soluble
                                               
  *Oncogenesis*                                
  EPHB2                                        EphB2 (EPHB2), tv-1
  BCL11A                                       B-cell CLL/lymphoma 11A (zinc finger protein) tv-1
  MAP17                                        Membrane-associated protein 17
  GDF15                                        Growth differentiation factor 15
                                               
  *Signalling*                                 
  RACGAP1                                      Rac GTPase activating protein 1
                                               
  *mRNA Processing*                            
  LSM5                                         LSM5 homolog, U6 small nuclear RNA associated (*S. cerevisiae*)
  THOC3                                        THO complex 3
                                               
  *Cell Adhesion*                              
  C20orf42                                     Chromosome 20 open reading frame 42
                                               
  *Translation*                                
  UK114                                        Translational inhibitor protein p14.5
                                               
  *Other*                                      
  ZCWCC2                                       Zinc finger, CW-type with coiled-coil domain 2
  KIAA1324                                     Maba1
  FLJ10514                                     Hypothetical protein FLJ10514
  ENC1                                         Ectodermal-neural cortex (with BTB-like domain)
  PTTG2                                        Pituitary tumour-transforming 2
  C21orf59                                     Chromosome 21 open reading frame 59
  WDR12                                        WD repeat domain 12
  LXN                                          Latexin protein
                                               
  *Other*                                      
  KIAA1892                                     KIAA1892
  KIAA1797                                     KIAA1797
  GLCE                                         Glucuronyl C5-epimerase
  KIAA0101                                     KIAA0101 gene product
  RRP46                                        Exosome component Rrp46
  S100P                                        S100 calcium binding protein P
  PRDX4                                        Peroxiredoxin 4
  FLJ20366                                     Hypothetical protein FLJ20366
  F12                                          Coagulation factor XII (Hageman factor)
  IGFBP2                                       Insulin-like growth factor binding protein 2 (36 kD)
  GW112                                        Differentially expressed in hematopoietic lineages
  C10orf3                                      Chromosome 10 open reading frame 3
  ATOH8                                        Atonal homolog 8 (*Drosophila*)
  MFN1                                         Mitofusin 1, nuclear gene encoding mitochondrial protein, tv-2
  QPCT                                         Glutaminyl-peptide cyclotransferase (glutaminyl cyclase)
  UBE2S                                        Ubiquitin-conjugating enzyme E2S

###### 

Genes commonly down-regulated 2-fold or more in colorectal FAP polyps compared to normal colon

  **Symbol**                                   **Gene Name**
  -------------------------------------------- -----------------------------------------------------------------------------------------------------------------
  *Cell Cycle Control*                         
  FOSB                                         FBJ murine osteosarcoma viral oncogene homolog B
  PPP3CB                                       Protein phosphatase 3, catalytic subunit, beta isoform (calcineurn A beta)
                                               
  *Cell Cycle*                                 
  MXI1                                         MAX interacting protein 1, tv-2
  CABLES1                                      Cdk5 and Abl enzyme substrate 1
  PMP22                                        Peripheral myelin protein 22, tv-3
  DTR                                          Diphtheria toxin receptor (heparin-binding epidermal growth factor-like growth factor)
                                               
  *Transcription/Transcriptional Regulation*   
  HLX1                                         H2.0-like homeo box 1 (*Drosophila*)
  NKX2--3                                      NK2 transcription factor related, locus 3 (*Drosophila*)
  SOX18                                        SRY (sex determining region Y)-box 18
  FNBP1                                        Formin-binding protein 1
  COL4A1                                       Collagen, type IV, alpha 1
  SIRT6                                        Sirtuin (silent mating type information regulation 2 homolog) 6 (*S. cerevisiae*)
  SIRT7                                        Sirtuin (silent mating type information regulation 2 homolog) 7 (*S. cerevisiae*)
  AIM1L                                        Absent in melanoma 1-like
  C19orf21                                     Chromosome 19 open reading frame 21
                                               
  *Transport*                                  
  FBXO32                                       F-box only protein 32, tv-2
  KCNMA1                                       Potassium large conductance calcium-activated channel, subfamily M, alpha member 1
  MYADM                                        Myeloid-associated differentiation marker
  AQP8                                         Aquaporin 8
  SLC17A4                                      Solute carrier family 17 (sodium phosphate), member 4
  SLCO2A1                                      Solute carrier organic anion transporter family, member 2A1
  SGK                                          Serum/glucocorticoid regulated kinase
  P2RX4                                        Purinergic receptor P2X, ligand-gated ion channel, 4, tv-2
  SLC20A1                                      Solute carrier family 20 (phosphate transporter), member 1
  VAMP5                                        Vesicle-associated membrane protein 5 (myobrevin)
                                               
  *Metabolism*                                 
  MGC4171                                      Hypothetical protein MGC4171
  LIPH                                         Lipase, member H
  KIAA0992                                     Palladin
  KIAA0828                                     KIAA0828 protein
  SULT1A2                                      Sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2, tv-1
  UPP1                                         Uridine phosphorylase 1, tv-1
  BTNL3                                        Butyrophilin-like 3, tv-2
  KIAA0934                                     KIAA0934 protein
  AK1                                          Adenylate kinase 1
  DPYSL3                                       Dihydropyrimidinase-like 3
  PLCD1                                        Phospholipase C, delta 1
  CA4                                          Carbonic anhydrase IV
  SVIL                                         Supervillin, tv-1
  PC                                           Pyruvate carboxylase, nuclear gene encoding mitochondrial protein, tv-2
  TMPRSS2                                      Transmembrane protease, serine 2
  PRSS3                                        Protease, serine, 3 (mesotrypsin)
  PCK1                                         Phosphoenolpyruvate carboxykinase 1 (soluble)
  ST6GALNAC6                                   CMP-NeuAC: (beta)-N-acetylgalactosaminide (alpha)2,6-sialyltransferase member IV
  RARRES2                                      Retinoic acid receptor responder (tazarotene induced) 2
                                               
  *Tumour Suppression*                         
  PPAP2A                                       Phosphatidic acid phosphatase type 2A, tv-1
                                               
  *Signalling*                                 
  RGL1                                         Ral guanine nucleotide dissociation stimulator-like 1
  EFNA1                                        Ephrin-A1, tv-1
  SDCBP2                                       Syndecan binding protein (syntenin) 2, tv-2
  GUCA2A                                       Guanylate cyclase activator 2A (guanylin)
  BSG                                          Basigin (OK blood group), tv-4
  TRIF                                         TIR domain containing adaptor inducing interferon-beta
  ILK                                          Integrin-linked kinase
  TJP3                                         Tight junction protein 3 (zona occludens 3)
  PRKCD                                        Protein kinase C, delta
  ITPKA                                        Inositol 1,4,5-trisposphate 3-kinase A
  IL2RG                                        Interleukin 2 receptor, gamma (severe combined immunodeficiency)
  LNK                                          Lymphocyte adaptor protein
                                               
  *Cell Adhesion*                              
  PC-LKC                                       Protocadherin LKC
  DCN                                          Decorin, tv-E
  FLNA                                         Filamin A, alpha (actin binding protein 280)
  MSN                                          Moesin
  SORBS1                                       Sorbin and SH3 domain containing 1
  TAGLN                                        Transgelin
  CDC42                                        Cell division cycle 42 (GTP binding protein, 25 kDa), tv-2
  COL4A2                                       Collagen, type IV, alpha 2
  DBN1                                         Drebin 1, tv-1
  GSN                                          Gelsolin (amyloidosis, Finnish type), tv-2
  ACTG2                                        Actin, gamma 2, smooth muscle, enteric
  ACTA2                                        Actin, alpha 2, smooth muscle, aorta
  CGN                                          Cingulin
                                               
  *Apoptosis*                                  
  RIPK3                                        Receptor-interacting serine-threonine kinase 3
  FOSL2                                        FOS-like antigen 2
  DAPK3                                        Death-associated protein kinase 3
  LGALS1                                       Lectin, galactoside-binding, soluble, 1 (galactin 1)
  GADD45B                                      Growth arrest and DNA-damage-inducible, beta
                                               
  *Structural*                                 
  CLDN5                                        Claudin 5 (transmembrane protein deleted in velocardiofacial syndrome)
  KRT19                                        Keratin 19
  TPM2                                         Tropomyosin 2 (beta)
                                               
  *Other*                                      
  DUSP5                                        Dual specificity phosphatase 5
  CLIPR-59                                     CLIP-170-related protein
  PTPRR                                        Protein tyrosine phosphatase, receptor type, R, tv-2
  SMTN                                         Smoothelin, tv-2
  CEACAM1                                      Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
  EPS8L2                                       EPS8-like 2
  RICH1                                        RhoGAP interacting with CIP4 homologs 1
  PDZK2                                        PDZ domain containing 2
  CHKL                                         Choline kinase-like, tv-1
  DIP13B                                       DIP13 beta
  NS5ATP13TP2                                  NS5ATP13TP2 protein
  M-RIP                                        Myosin phosphatase-Rho interacting protein
                                               
  MTMR9                                        Myotubularin related protein 9
  LRRC1                                        Leucine rich repeat containing 1
  CTGF                                         Connective tissue growth factor
  DSCR1L1                                      Down syndrome critical region gene 1-like 1
  TU12B1-TY                                    TU12B1-TY protein
  MYH11                                        Myosin, heavy polypeptide 11, smooth muscle, tv-SM1
  FLJ23471                                     MICAL-like 2, tv-2
  DKFZP434B044                                 Hypothetical protein DKFZp434B044
  MUCDHL                                       Mucin and cadherin-like, tv-2
  MMP28                                        Matrix metalloproteinase 28, tv-1
  TRIM15                                       Tripartite motif-containing 15, tv-1
  COL6A2                                       Collagen, type VI, alpha 2, tv-2C2
  SELM                                         Selenoprotein SelM
  ZAK                                          Sterile alpha motif and leucine zipper containing kinase AZK
  SMTN                                         Smoothelin, tv-3
  TNXB                                         Tenascin XB, tv-XB-S
  EPS8L1                                       EPS8-like 1, tv-3
  FLJ10350                                     Hypothetical protein FLJ10350
  DKFZP762C186                                 Tangerin
  TBC1D1                                       TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1
  KIAA1145                                     KIAA1145 protein
  PKIG                                         Protein kinase (cAMP-dependent, catalytic) inhibitor gamma, tv-2
  PKIB                                         Protein kinase (cAMP-dependent, catalytic) inhibitor beta, tv-3
  IGSF9                                        Immunoglobulin superfamily, member 9
  LOC90313                                     Hypothetical protein BC004507
  FLJ22582                                     Hypothetical protein FLJ22582
  KIAA0063                                     KIAA0063 gene product
  FSTL1                                        Follistatin-like 1
  PRNP                                         Prion protein (Creutzfeld-Jakob disease, Gerstmann-Strausler-Scheinker syndrome, fatal familial insomnia), tv-2
  ANKRD25                                      Ankyrin repeat domain 25
  STOM                                         Stomatin, tv-2
  FLJ46603                                     FLJ46603 protein
  RAIN                                         Ras-interacting protein
  DHRS9                                        Dehydrogenase/reductase (SDR family) member 9, tv-1
  LIMS2                                        LIM and senescent cell antigen-like domains 2
  ARHGEF18                                     Rho/rac guanine nucleotide exchange factor (GEF) 18
  KIAA0285                                     KIAA0285 gene product
  PDLIM7                                       PDZ and LIM domain 7 (enigma), tv-1
  CXX1                                         CAAX box 1
  MGP                                          Matrix GIa protein
  PTPRH                                        Protein tyrosine phosphatase, receptor type, H
  SPARC                                        Secreted protein, acidic, cysteine-rich (osteonectin)
  FLJ90022                                     Hypothetical protein FLJ90022
  SERPING1                                     Serine (or cysteine) proteinase inhibitor, clade G (C1 inhibitor), member 1, (angioedema, hereditary)
  CSRP1                                        Cysteine and glycine-rich protein 1
  KIAA0513                                     KIAA0513 gene product
                                               
  OAS1                                         2\',5\'-oligoadenylate synthetase 1, 40/46 kDa

Cluster analysis was performed using GeneSpring 5.0 software in order to further characterise the similarity across the FAP samples and to determine if there was differential gene expression compared to healthy colon tissue. The stomach FAP duplicates display profiles slightly distinct from the other FAP adenomas. The normal colon duplicate profiles are unique to all other profiles (Figure [1](#F1){ref-type="fig"}).

![**Cluster analysis of FAP polyps and mixed normal colon**. The columns represent the gene expression profiles of each sample. Green -- low expression level, yellow -- medium expression level, red -- high expression level. The relationships between each sample are shown by the upper dendrogram. The colouring in the upper dendrogram represents the sample type: green (left) -- normal colon; blue -- colorectal FAP polyps; yellow -- stomach FAP. 1 -- Normal Colon Duplicate; 2 -- Normal Colon Duplicate; 3 -- Colorectal FAP Polyp A Duplicate; 4 -- Colorectal FAP Polyp A Duplicate; 5 -- Colorectal FAP Polyp D Duplicate; 6 -- Colorectal FAP Polyp D Duplicate; 7 -- Colorectal FAP Polyp B Duplicate; 8 -- Colorectal FAP Polyp B Duplicate; 9 -- Colorectal FAP Polyp C Duplicate; 10 -- Colorectal FAP Polyp C Duplicate; 11 -- Stomach FAP Polyp D Duplicate; 12 -- Stomach FAP Polyp D Duplicate.](1897-4287-5-2-79-1){#F1}

Differential gene expression analysis in desmoid tumours and control fibroblasts
--------------------------------------------------------------------------------

The average expression in the desmoid tumours was compared to the control fibroblast cell line and significantly altered expression identified by differential gene expression analysis. Genes in each analysis were excluded if their fluorescence detection score was less than 0.99, and if their differential score was less than 13 (p \> 0.05). Genes with differential expression and up- or down-regulated more than 2-fold in the desmoid tumour samples compared to the normal fibroblast cell line were compiled into lists (Tables [5](#T5){ref-type="table"} and [6](#T6){ref-type="table"}).

###### 

Genes commonly up-regulated 2-fold or more in desmoid tumours compared to normal fibroblast cells

  **Symbol**                                   **Gene Name**
  -------------------------------------------- ------------------------------------------------------------------------------------------------
  *Cell Cycle Control*                         
  PTN                                          Pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1)
  GAS7                                         Growth arrest-specific 7, tv-b
  CDKN1C                                       Cyclin-dependent kinase inhibitor 1C (p57, Kip2)
  TGFB3                                        Transforming growth factor, beta 3
                                               
  *Cell Cycle*                                 
  NEK3                                         NIMA (never in mitosis gene a)-related kinase 3, tv-2
                                               
  *Transcription/Transcriptional Regulation*   
  BHLHB2                                       Basic helix-loop-helix domain containing, class B, 2
  COL4A1                                       Collagen, type IV, alpha 1
  COL4A2                                       Collagen, type IV, alpha 2
  DNAJB2                                       DnaJ (Hsp40) homolog, subfamily B, member 2
  ELF2                                         E74-like factor 2 (ets domain transcription factor), tv-1
  EVI1                                         Ecotropic viral integration site 1
  FKBP1A                                       FK506 binding protein 1A, 12 kDa, tv-12A
  FLJ10404                                     Hypothetical protein FLJ10404
  HDAC8                                        Histone deacetylase 8
  JUN                                          v-jun sarcoma virus 17 oncogene homolog (avian)
  KIF2C                                        Kinesin family member C2
  NUCKS                                        Nuclear ubiquitous casein kinase and cyclin-dependent kinase substrate
  PBX2                                         Pre-B-cell leukemia transcription factor 2
  PPIE                                         Peptidylprolyl isomerase E (cyclophilin E), tv-2
  PRR3                                         Proline-rich polypeptide 3
  TEAD2                                        TEA domain family member 2
  TLE2                                         Transducin-like enhancer of split 2 (E(sp1)) homolog, *Drosophila*
  TLE4                                         Transducin-like enhancer of split 4 (E(sp1)) homolog, *Drosophila*
  ZNF22                                        Zinc finger protein 22 (KOX15)
  ZNF254                                       Zinc finger protein 254
  TDRD3                                        Tudor domain containing 3
  ZNF300                                       Zinc finger protein 300
  MEF2C                                        MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C)
  NAB1                                         NGFI-A binding protein 1 (EGR1 binding protein 1)
  Hes4                                         bHLH factor Hes4
  C19orf13                                     Chromosome 19 open reading frame 13
  ARNT                                         Aryl hydrocarbon receptor nuclear translocator, tv-2
  ZNF266                                       Zinc finger protein 266
  ZNF26                                        Zinc finger protein 26 (KOX 20)
  MGC51082                                     Hypothetical protein MGC51082
  TGIF2                                        TGFB-induced factor 2 (TALE family homeobox)
  MYST3                                        MYST histone acetyltransferase (monocytic leukemia) 3
  M96                                          Likely ortholog of mouse metal response element binding transcription factor 2
  BAZ2B                                        Bromodomain adjacent to zinc finger domain, 2B
                                               
  *Transport*                                  
  NXT1                                         NTF2-like export factor 1
  ABCA1                                        ATP-binding cassette, sub-family A, member 1
  SLC25A29                                     Solute carrier family 25, member 29
  SLC16A9                                      Solute carrier family 16 (monocarboxylic acid transporters), member 9
  PSCD1                                        Pleckstrin homology, Sec7 and coiled-coil domains 1(cytohesin 1), tv-2
  AQP1                                         Aquaporin 1(Channel-forming integral protein, 28 kDa) tv-1
  SCNN1D                                       Sodium channel, nonvoltage-gated, delta
  SLC22A17                                     Solute carrier family 22 (organic cation transporter), member 17, tv-2
                                               
  *Metabolism*                                 
  SULT1A1                                      Sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1, tv-1
  CH25H                                        Cholesterol 25-hydroxylase
  QTRTD1                                       Queuine tRNA-ribosyltransferase domain containing 1
  FLJ23749                                     Hypothetical protein FLJ23749
  FLJ10706                                     Hypothetical protein FLJ10706
  USP52                                        Ubiquitin specific protease 52
  RARRES2                                      Retinoic acid receptor responder (tazarotene induced) 2
  ADAM19                                       A distintegrin and metalloproteinase domain 19 (meltrin beta), tv-2
  AUTS2                                        Autism susceptibility candidate 2
  GALNT3                                       UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3)
  KIAA0140                                     KIAA0140
  ODC-p                                        Ornithine decarboxylase-like
  PCSK5                                        Proprotein convertase subtilisin/kexin type 5
                                               
  *Oncogenesis*                                
  AKAP13                                       A kinase (PRKA) anchor protein 13, tv-3
  MGP                                          Matrix Gla protein
  EWSR1                                        Ewing sarcoma breakpoint region 1, tv-EWS-b
  SFRP4                                        Secreted frizzled-related protein 4
  SRPUL                                        Sushi-repeat protein
                                               
  *Signalling*                                 
  GABBR1                                       Gamma-aminobutyric acid (GABA) B receptor, 1, tv-2
  CAPS                                         Calcyphosine, tv-2
  NET1                                         Neuroepithelial cell transforming gene 1
  PRKCH                                        Protein kinase C, eta
  PPP2R2B                                      Protein phosphatase 2 (formerly 2A), regulatory subunit B (PR52), beta isoform, tv-4
  RGS16                                        Regulator of G-protein signalling 16
  PTHR1                                        Parathyroid hormone receptor 1
  TMPEI                                        Transmembrane, prostate androgen induced RNA, tv-4
  ARHU                                         Ras homolog gene family, member U
  CHN1                                         Chimerin (chimaerin) 1
  EFNB3                                        Ephrin-B3
  GFRA2                                        GDNF family receptor alpha 2
  GNB4                                         Guanine nucleotide binding protein (G protein), beta polypeptide 4
  IL11RA                                       Interleukin 11 receptor, alpha, tv-1
  ITPKB                                        Inositol 1,4,5-trisphosphate 3-kinase B
  KIF13B                                       Kinesin family member 13B
  MAP4K1                                       Mitogen-activated protein kinase kinase kinase kinase 1
  MLP                                          MARCKS-like protein
  PDGFRL                                       Platelet-derived growth factor receptor-like
  PRKCABP                                      Protein kinase C, alpha binding protein
  RASD1                                        RAS, dexamethasone-induced 1
  TNFAIP6                                      Tumour necrosis factor, alpha-induced protein 6
                                               
  *Cell Adhesion*                              
  COL7A1                                       Collagen, type VII, alpha 1 (epidermolysis bullosa, dystrophic, dominant and recessive)
  ISLR                                         Immunoglobulin superfamily containing leucine-rich repeat, tv-1
                                               
  *Apoptosis*                                  
  PPP1R13B                                     Protein phosphatase 1, regulatory (inhibitor) subunit 13B
  AXUD1                                        AXIN1 up-regulated 1
  CASP10                                       Caspase 10, apoptosis-related cysteine protease, tv-B
  MX1                                          Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse)
  PCBP4                                        Poly(rC) binding protein 4, tv-4
  TNFRSF19                                     Tumour necrosis factor receptor superfamily, member 19, tv-2
  TNFRSF25                                     Tumour necrosis factor receptor superfamily, member 25, tv-7
                                               
  *Tumourigenesis*                             
  BARD1                                        BRCA1 associated RING domain 1
  LOH11CR2A                                    Loss of heterozygosity, 11, chromosomal region 2, gene A
                                               
  *Immune Response*                            
  HLA-DPA1                                     Major histocompatibility complex, class II, DP alpha 1
  C1R                                          Complement component 1, r subcomponent
  CXCL14                                       Chemokine (C-X-C motif) ligand 14
  IFI27                                        Interferon, alpha-inducible protein 27, tv-α
  MX2                                          Myxovirus (influenza virus) resistance 2 (mouse)
                                               
  *RNA Processing*                             
  DHX8                                         DEAH (Asp-Glu-Ala-His) box polypeptide 8
  HNRPA1                                       Heterogeneous nuclear ribonucleoprotein A1, tv-1
  SFRS11                                       Splicing factor, arginine/serine-rich 11
                                               
  *Structural*                                 
  ACTL6                                        Actin-like 6
  FBLN1                                        Fibulin 1 (FBLN1), tv-C
  FBLN1                                        Fibulin 1 (FBLN1), tv-D
  SMTN                                         Smoothelin, tv-2
                                               
  *Other*                                      
  MT1H                                         Metallothionein 1H
  C12orf14                                     Chromosome 12 open reading frame 14
  PELI1                                        Pellino homolog 1 (*Drosophila*)
  IFI44                                        Interferon-induced protein 44
  C10orf6                                      Chromosome 10 open reading frame 6
  C2orf11                                      Chromosome 2 open reading frame 11
  FLJ31951                                     Hypothetical protein FLJ31951
  ISYNA1                                       Myo-inositol 1-phosphate synthase A1
  FLJ31614                                     Hypothetical protein FLJ31614
  AD031                                        AD031 protein
  CASC3                                        Cancer susceptibility candidate 3
  GBA2                                         Glucosidase, beta (bile acid) 2
  CGI-85                                       CGI-85 protein, tv-2
  C14orf80                                     Chromosome 14 open reading frame 80
  ACAS2L                                       Acetyl-Coenzyme A synthetase 2 (AMP forming)-like, nuclear gene encoding mitochondrial protein
  DTX3                                         Deltex 3 homolog (*Drosophila*)
  FLJ23059                                     Hypothetical protein FLJ23059
  PIK3R1                                       Phosphoinositide-3-kinase, regulatory subunit, polypeptide 1 (p85 alpha), tv-2
  KIAA1223                                     KIAA1223
  STARD9                                       START domain containing 9
  LOC375786                                    Hypothetical gene supported by AL713796
  SR140                                        U2-associated SR140 protein
  MIDN                                         Midnolin
  SEC31L2                                      SEC31-like 2 (*S. cerevisiae*), tv-1
  FLJ12178                                     Hypothetical protein FLJ12178
  LOC157567                                    Hypothetical protein LOC157567
  FLJ25005                                     FLJ25005 protein
  WARP                                         von Willebrand factor A domain-related protein, tv-1
  KIAA1036                                     KIAA1036
  LOC374969                                    Hypothetical protein LOC374969
  LOC155435                                    Hypothetical protein LOC155435
  MGC9913                                      Hypothetical protein MGC9913
  CASKIN2                                      CASK interacting protein 2
  CFDP1                                        Craniofacial development protein 1
  SPAG5                                        Sperm associated antigen 5
  MMP23B                                       Matrix metalloproteinase 23B
  AKAP8L                                       A kinase (PRKA) anchor protein 8-like
  FLJ11029                                     Hypothetical protein FLJ11029
  DDIT4                                        DNA-damage-inducible tv-4
  APCDD1                                       Adenomatous Polyposis Coli down-regulated 1
  CDW92                                        CDW92 antigen

###### 

Genes commonly down-regulated 2-fold or more in desmoid tumours compared to normal fibroblast cells

  **Symbol**                                   **Gene Name**
  -------------------------------------------- ------------------------------------------------------------------------------------------------------------
  *Cell Cycle*                                 
  GRN                                          Granulin
  QSCN6                                        Quiescin Q6
  STAT1                                        Signal transducer and activator of transcription 1,91 kDa, tv-α
  STAT1                                        Signal transducer and activator of transcription 1,91 kDa, tv-β
  TIMP1                                        Tissue inhibitor of metalloproteinase 1 (erythroid potentiating activity, collagenase inhibitor)
                                               
  *Transcription/Transcriptional Regulation*   
  HIST1H2BK                                    Histone 1, H2bk
  LOXL1                                        Lysyl oxidase-like 1
  MSC                                          Musculin (activated B-cell factor-1)
  PRRX1                                        Paired related homeobox 1, tv-pmx-1b
  ZDHHC14                                      Zinc finger, DHHC domain containing 14
                                               
  *Transport*                                  
  GLRB                                         Glycine receptor, beta
  PCOLCE2                                      Procollagen C-endopeptidase enhancer 2
  SCAMP3                                       Secretory carrier membrane protein 3, tv-1
  SLC31A2                                      Solute carrier family 31 (copper transporters), member 2
                                               
  *Metabolism*                                 
  AK1                                          Adenylate kinase 1
  AKR1C3                                       Aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II)
  C1RL                                         Complement component 1, r subcomponent-like
  COMT                                         Catechol-O-methyltransferase, tv-MB-COMT
  CTSL                                         Cathepsin L, tv-2
  GCLM                                         Glutamate-cysteine ligase, modifier subunit
  GNPDA2                                       Glucosamine-6-phosphate deaminase 2
  IDH1                                         Isocitrate dehydrogenase 1 (NADP+), soluble
  NQO1                                         NAD(P)H dehydrogenase, quinone 1
  PTGIS                                        Prostaglandin I2 (prostacyclin) synthase
  SMPDL3A                                      Sphingomyelin phosphodiesterase, acid-like 3A
  SPPL2A                                       Putative intramembrane cleaving protease
  STS                                          Steroid sulfatase (microsomal), arylsulfatase C, isozyme S
  UBE2G1                                       Ubiquitin-conjugating enzyme E2G 1 (UBC7 homolog, *C. elegans*), tv-1
  UCHL1                                        Ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
                                               
  *Tumour Suppression*                         
  MADH3                                        MAD, mothers against decapentaplegic homolog 3 (*Drosophila*)
                                               
  *Signalling*                                 
  DEPDC6                                       DEP domain containing 6
  DIRAS1                                       DIRAS family, GTP-binding RAS-like 1
  PDGFRA                                       Platelet-derived growth factor receptor, alpha polypeptide
  PENK                                         Proenkephalin
  SARA2                                        SAR1a gene homolog 2 (*S. cerevisiae*)
  SNTB1                                        Syntrophin, beta 1 (dystrophin-associated protein A1, 59 kDa, basic component 1)
  DKFZp564I1922                                Adlican
                                               
  *mRNA Processing*                            
  CSTF1                                        Cleavage stimulation factor, 3\' pre-RNA, subunit 1, 50 kDa
                                               
  *Cell Adhesion*                              
  CNTNAP1                                      Contactin-associated protein 1
  THBS2                                        Thrombospondin 2
  ZYX                                          Zyxin
                                               
  *Apoptosis*                                  
  C20orf97                                     Chromosome 20 open reading frame 97
  DAPK1                                        Death-associated protein kinase 1
  MAPK1                                        Mitogen-activated protein kinase 1, tv-1
                                               
  *Structural*                                 
  KRT18                                        Keratin 18, tv-1
  TUBG1                                        Tubulin, gamma 1
                                               
  *Immune Response*                            
  ANKRD15                                      Ankyrin repeat domain 15, tv-1
  DPP4                                         Dipeptidylpeptidase 4 (CD26, adenosine deaminase complexing protein 2)
  MR1                                          Major histocompatibility complex, class I-related
                                               
  *Other*                                      
  ANGPTL2                                      Angiopoietin-like 2
  ANTXR2                                       Anthrax toxin receptor 2
  BCKDHB                                       Branched chain keto acid dehydrogenase E1, beta polypeptide (maple syrup urine disease), nuclear gene
                                               encoding mitochondrial protein, tv-2
  BZRP                                         Benzodiazapine receptor (peripheral), tv-PBR-S
  C11orf17                                     Chromosome 11 open reading frame 17, tv-2
  C6orf32                                      Chromosome 6 open reading frame 32
  C9orf88                                      Chromosome 9 open reading frame 88
  CDC42EP2                                     CDC42 effector protein (Rho GTPase binding) 2
  CRLF1                                        Cytokine receptor-like factor 1
  DIRC2                                        Disrupted in renal carcinoma 2
  EDEM1                                        ER degradation enhancer, mannosidase alpha-like 1
  FLJ20073                                     FLJ20073 protein
  FLJ20272                                     Hypothetical protein FLJ20272
  FLJ22582                                     Hypothetical protein FLJ22582
  HOM-TES-103                                  HOM-TES-103 tumour antigen-like, tv-3
  HSPC157                                      HSPC157 protein
  KIAA0196                                     KIAA0196 gene product
  LOC196463                                    Hypothetical protein LOC196463
  LOC221091                                    Similar to hypothetical protein
  LOC286343                                    Hypothetical protein LOC286343
  LOC387908                                    Similar to Ferritin heavy chain (Ferritin H subunit)
  LOC57168                                     Similar to aspartate beta hydroxylase (ASPH)
  LRRFIP2                                      Leucine rich repeat (in FLII) interacting protein 2
  LYPLA1                                       Lysophospholipase I
  MGC12992                                     Hypothetical protein MGC12992
  MGST1                                        Microsomal glutathione S-transferase 1, tv-1a
  MOCOS                                        Molybdenum cofactor sulfurase
  NNT                                          Nicotinamide nucleotide transhydrogenase
  PKM2                                         Pyruvate kinase, muscle, tv-1
  PPAP2B                                       Phosphatidic acid phosphatase type 2B, tv-2
  PSFL                                         Anterior pharynx defective 1B-like
  PTX3                                         Pentaxin-related gene, rapidly induced by IL-1 beta
  S100A4                                       S100 calcium binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog), tv-2
  SLIT3                                        Slit homolog 3 (*Drosophila*)
  SMP1                                         Small membrane protein 1
  TRIM4                                        Tripartite motif-containing 4, tv-β
  UNQ564                                       UNQ564
  ZC3HAV1                                      Zinc finger CCCH type, antiviral 1, tv-2

To reveal any correlation between the expression profiles of desmoid tumours and FAP adenomas, the data from each group were compared. In the upper dendrogram (Figure [2](#F2){ref-type="fig"}) it can be seen that all the FAP adenomas cluster in the same group. The desmoid tumours and the normal fibroblast cell line clustered in an entirely different group to the FAP samples. The FAP adenomas and the normal colon have distinct gene profiles compared to the desmoid tumours and the normal fibroblasts. Within the FAP adenomas, the stomach adenoma and the normal colon have slightly different gene profiles compared to the colorectal adenomas.

![**Cluster analysis of FAP polyps, normal colon, desmoid tumours and normal fibroblasts**. The columns represent the gene expression profiles of each sample. Green -- low expression level, yellow -- medium expression level, red -high expression level. The relationships between each sample are shown by the upper dendrogram. The colouring in the upper dendrogram represents the sample type: green (left) -- normal colon; blue -- colorectal FAP polyps; orange -- stomach FAP polyp; green (right) -- desmoid tumours; purple -- fibroblast cell line. 1 -- Normal Colon Duplicate; 2 -- Normal Colon Duplicate; 3 -- Colorectal FAP Polyp A Duplicate; 4 -- Colorectal FAP Polyp A Duplicate; 5 -- Colorectal FAP Polyp D Duplicate; 6 -- Colorectal FAP Polyp D Duplicate; 7 -- Colorectal FAP Polyp B Duplicate; 8 -- Colorectal FAP Polyp B Duplicate; 9 -- Colorectal FAP Polyp C Duplicate; 10 -- Colorectal FAP Polyp C Duplicate; 11 -- Stomach FAP Polyp D Duplicate; 12 -- Stomach FAP Polyp D Duplicate; 13 -- Desmoid Tumour A Duplicate; 14 -- Desmoid Tumour A Duplicate; 15 -- Desmoid Tumour C Duplicate; 16 -- Desmoid Tumour C Duplicate; 17 -- Fibroblast Cell Line Duplicate; 18 -- Fibroblast Cell Line Duplicate.](1897-4287-5-2-79-2){#F2}

Discussion
==========

In this study, 24 K Illumina HumRef-8 BeadArrays were used to compare gene expression of FAP adenomas, desmoid tumours and normal fibroblasts. To date there have been a number of small scale gene expression studies on FAP adenoma tissue, the vast majority of which have employed immunohistochemistry (IHC). Most of these studies have been performed on individual genes that include E-cadhein, α-, β- and -catenin, COX-1, COX-2, and c-myc \[[@B20]-[@B25]\]. In addition, one study used semi-quantitative RT-PCR to study GKLF \[[@B26]\]. The only report examining global gene expression in human FAP adenoma tissue identified 84 differentially expressed genes in adenomas compared to normal colon tissue \[[@B27]\].

In this study, the gene expression profiles obtained from the FAP adenomas indicate that colorectal adenomas are similar but distinctly different to the stomach adenomas. There were a large number of commonly expressed genes identified across the colorectal FAP adenomas, but when the differentially expressed genes from the stomach adenoma were included in the analysis the number of commonly expressed genes decreased dramatically. The genes that were differentially expressed in the four colonic adenomas and one stomach adenoma were investigated more closely in an attempt to identify common genetic features in FAP. From this analysis genes involved in the cell cycle, transcription and metabolism were the most frequently up-regulated. The most frequently down-regulated genes included those involved in metabolism, cell adhesion, signal transduction, transcription and transport. Since adenomas develop due to a breakdown in the fidelity of the Wnt signalling pathway it was not surprising to observe the over-expression of genes involved in cell cycle progression.

Altered Expression of Wnt/β-catenin Target Genes in Colorectal FAP Adenomas
---------------------------------------------------------------------------

It has been long established that deregulation of the Wnt signalling pathway due to APC mutations plays a major role in the progression of FAP \[[@B5]\]. The Wnt/β-catenin signalling pathway is involved in the control of expression of Sox9, PTTG1 and EphB2, all of which were found to be up-regulated by more than 2-fold in all the colorectal FAP adenomas compared to the normal colon.

PTTG1 is regulated by a TCF binding sequence in its promoter region \[[@B28]\]. The normal function of PTTG1 is to regulate chromosome segregation during cell division \[[@B29]\]. Over-expression of PTTG1 has been reported frequently in various types of cancer, including colorectal, and has been associated with angiogenesis \[[@B30]-[@B32]\]. The role of PTTG1 in angiogenesis is thought to be a result of its part in mediating the secretion of the basic fibroblast growth factor into the extracellular matrix, which promotes proliferation and migration of colorectal cancer cells \[[@B30],[@B31]\].

The Sox9 gene encodes a transcription factor that is required for chondrogenesis and male gonad development \[[@B32]\], which is under the control of the Wnt signalling pathway \[[@B33]\]. The expression of the Sox9 gene in the intestine is dependent on the activity of the β-catenin/TCF-4 complex, although it is unknown whether this complex interacts directly with the Sox9 promoter or through another of its targets \[[@B33]\].

The EphB2 gene encodes the Eph receptor B, which has been shown to be a target of the Wnt signalling pathway \[[@B34]\]. There is evidence to suggest that normal patterning in the epithelium of the intestinal crypts is coordinated by EphB2 and its ligand, ephrin B \[[@B34]\]. Over-expression of EphB2 is often found in colorectal cancers, but there is confusion about its role in tumourigenesis. Many studies on other tumours have reported EphB2 over-expression as a marker of poor prognosis, but recent studies in colorectal cancer have suggested otherwise \[[@B35],[@B36]\].

Altered Expression of Cell Cycle-Related Genes in Colorectal FAP Adenomas
-------------------------------------------------------------------------

A number of genes found to be commonly up-regulated in the adenomas used in this study have previously been reported as being over-expressed in various types of cancers. These genes include the cell cycle-related genes Chromosome condensation protein G (HCAP-G), Protein regulator of cytokinesis 1 (PRC1), SMC4 structural maintenance of chromosome 4-like 1 (SMC4L1) and Cyclin B2 (CCNB2) \[[@B37]-[@B39]\]. Although these genes are associated with tumour development none have been thoroughly characterized in FAP to date.

Altered Gene Expression in Desmoid Tumours
------------------------------------------

A limited number of gene expression studies have been performed on desmoid tumours, primarily due to the difficulties in obtaining tissue. Two reports have studied gene expression in desmoid disease using 6.8 K, 19 K and 33 K Affymetrix microarrays \[[@B40],[@B41]\]. Skubitz and Skubitz (2004) \[[@B40]\] reported that ADAM12, WISP-1, Sox-11 and fibroblast activation protein-a are uniquely expressed in desmoids. Denys et al. (2004) identified 69 differentially expressed genes in desmoid tumour tissue compared to normal fibroblasts, before focusing on the down-regulation of IGFBP-6 \[[@B41]\].

A number of genes that were identified as being differentially expressed in desmoid tumours in this study have been reported previously. The over-expressed genes include transforming growth factor β3 (TGFβ3), a distintegrin and metalloproteinase domain 19 (ADAM19), chimerin 1 (CHN1), and ephrin-B3 (EFNB3) \[[@B40],[@B41]\]. The under-expressed genes include quiescin Q6 (QSCN6), prostaglandin I2 synthase (PTGIS), proenkephalin (PENK), keratin 18 (KRT18), cytokine receptor-like factor 1 (CRLF1), pentaxin-related gene (PTX3) and endoglin (ENG) \[[@B41]\].

Ephrin-B3, a Wnt Target Overexpressed in Desmoid Tumours
--------------------------------------------------------

The known Wnt/β-catenin target gene ephrin-B3 \[[@B42]\] has been found in this study to be up-regulated more than 2-fold in desmoid tumours compared to normal fibroblasts. The ephrins are ligands for the EPH receptor family, whose normal function is to organize cell patterning in the intestinal crypts \[[@B34]\]. In addition, more recent observations suggest that ephrins are tumour suppressors, although the mechanism by which this is affected remains to be clarified \[[@B3],[@B43],[@B44]\]. Further investigation into the precise role of ephrin-B3 is required before any conclusions can be made regarding its role in desmoid disease.

Wound Healing-Associated Genes Differentially Expressed in Desmoid Tumours
--------------------------------------------------------------------------

Two genes, transforming growth factor β-3 (TGFβ3) and pleiotrophin (PTN), were found to be differentially expressed in desmoid tumours. Both genes are associated with wound healing and could potentially explain the growth advantage of desmoid tumours \[[@B45]\].

TGFβ3 is a multifunctional protein, having roles in cell proliferation and differentiation during embryogenesis and wound healing \[[@B46]\]. Pleiotrophin has been reported to be strongly expressed in many human cancers, and is thought to promote malignant transformation and angiogenesis \[[@B47]\]. It is also frequently found to be up-regulated during the wound healing process \[[@B48]\].

In this study, three genes associated with negative regulation of the wound response have been identified as being under-expressed in desmoid tumours. The three genes are: signal transducer and activator of transcription 1 (STAT1), mothers against decapentaplegic homolog 3 (MADH3 or Smad3) and mothers against decapentaplegic homolog 6 (MADH6 or Smad6). STAT1 enhances transcription in response to interferon-, an action which has been shown to inhibit the wound healing response by preventing phosphorylation of Smad2 and Smad3 \[[@B49]\]. This in turn inhibits the action of TGFβ on the wound response \[[@B50]\]. The role of Smad3 in the wound response is not entirely understood; however, the absence of Smad3 causes an accelerated healing response, even though its over-expression has also been shown to promote healing \[[@B51],[@B52]\]. Smad6 is a known inhibitor of TGFβ, and has shown to be down-regulated in keloids \[[@B53]\].

The abundance of wound response-related genes found to be deregulated in the desmoid tumours in this study adds to the notion that desmoid formation is an abnormal wound response. The finding of over-expressed genes involved in fibroblast proliferation and migration could explain the abnormal proliferation and local invasiveness of desmoid tumours. The down-regulation of angiogenesis-associated genes could account for the poor vascularisation of desmoids.

The limiting factor in this study of desmoid tumours is the small number of desmoids available. In order to reach more conclusions regarding the exact molecular nature of desmoids and their growth mechanisms, a much larger sample size would be required.

Comparison of FAP Adenoma and Desmoid Tumour Molecular Profiles
---------------------------------------------------------------

It has long been recognized that desmoid tumours occur with a much higher frequency in FAP patients than in the general population. The apparent role of aberrant Wnt signalling in both diseases could indicate a molecular similarity between the two. Although Wnt target genes were identified as being up-regulated in both tumour types in this study, the specific genes were different in the two groups. The finding of different Wnt targets could be attributed to the use of different control groups for the FAP adenomas and desmoid tumours. Nevertheless, the molecular profiles obtained using cluster analysis clearly demonstrated that FAP adenomas and desmoid tumours display distinctly different gene expression profiles.
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